TickerFactsScreenerDevelopers

REGENEREX PHARMA, INC. (RGPX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$57.7K2017: $2.6K2018: $36.1K2019: $47.1K2020: -$291.2K2021: -$62.7K2022: -$69.9K2023: -$76.2K2024: -$457.5K2025: -$1.63M-$1.63M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.63M-255.2%
2024-$457.5K-500.7%
2023-$76.2K-8.9%
2022-$69.9K-11.6%
2021-$62.7K+78.5%
2020-$291.2K-718.8%
2019$47.1K+30.3%
2018$36.1K+1303.9%
2017$2.6K—
2012-$57.7K—